KLTO
NASDAQ
Klotho Neurosciences, Inc. - Common Stock
Healthcare
· Biotechnology
$0.52
▲ +$0.00
(+0.00%)
Vol 2.1M
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$21.0M
ROE
-201.6%
D/E
0.00
Beta
2.35
52W
$0–$4
Price Chart
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -325.9% | -663.1% | -325.9% | -325.9% | -325.9% | -201.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 280.26 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 135.74 | 0.29 | 135.74 | 135.74 | 135.74 | 83.69 |
Key Ratios
ROA (TTM)
-171.3%
P/B
8.0
EPS (TTM)
$-0.33
52W High
$3.91
52W Low
$0.11
$0.11
52-Week Range
$3.91
How does KLTO compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
KLTO valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
8.0
▲
227%
above
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
KLTO profitability vs Biotechnology peers
ROE
-201.6%
▼
200%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-171.3%
▼
267%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
KLTO financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
83.7
▲
1785%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
2.4
▲
142%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
KLTO fundamentals radar
KLTO
Peer median
Industry
KLTO profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
KLTO vs peers: key metrics
Latest News
No related news yet